Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicentre, Ambispective, Observational, Real Life Study to Assess the Quality of Life Effectiveness of Extended Release (ER) Oral Cysteamine Therapy (Procysbi) in Belgian Patients Suffering From Nephropathic Cystinosis

NCT04246060 is registered in ClinicalTrials.gov with Chiesi SA/NV as lead sponsor.

NCT NCT04246060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04246060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicentre, Ambispective, Observational, Real Life Study to Assess the Quality of Life Effectiveness of Extended Release (ER) Oral Cysteamine Therapy (Procysbi) in Belgian Patients Suffering From Nephropathic Cystinosis
Lead sponsor
Chiesi SA/NV
Phase
Observational
Overall status
Unknown status
Start date
July 31, 2020
Completion date
July 1, 2026
Enrollment
31 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

nephropathic cystinosis